Sonoma Pharmaceuticals, Inc. — Director's Dealing 2018

Jan 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sonoma Pharmaceuticals, Inc. (SNOA)
CIK: 0001367083
Period of Report: 2018-01-02

Reporting Person: Schutz James J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-02	Common Stock, $0.0001 par value per share	A	17211	—	Acquired	33385	Direct

Footnotes

F1: The stock was granted by the Issuer as a bonus for services and vests immediately.